Presentation is loading. Please wait.

Presentation is loading. Please wait.

Relationship of exhaled nitric oxide to clinical and inflammatory markers of persistent asthma in children  Robert C. Strunk, MD, Stanley J. Szefler,

Published byDamon Shelton Modified over 5 years ago

Similar presentations

Presentation on theme: "Relationship of exhaled nitric oxide to clinical and inflammatory markers of persistent asthma in children  Robert C. Strunk, MD, Stanley J. Szefler,"— Presentation transcript:

1 Relationship of exhaled nitric oxide to clinical and inflammatory markers of persistent asthma in children  Robert C. Strunk, MD, Stanley J. Szefler, MD, Brenda R. Phillips, MS, Robert S. Zeiger, MD, PhD, Vernon M. Chinchilli, PhD, Gary Larsen, MD, Kevin Hodgdon, RRT, Wayne Morgan, MD, Christine A. Sorkness, PharmD, Robert F. Lemanske, MD  Journal of Allergy and Clinical Immunology  Volume 112, Issue 5, Pages (November 2003) DOI: /j.jaci

2 FIG 1 Study design for the National Heart, Lung, and Blood Institute's Childhood Asthma Research and Education Network study entitled “Characterizing the Response to a Leukotriene Receptor Antagonist and an Inhaled Corticosteroid.” ACQ, Asthma Control Questionnaire; MATAQ, Modified Asthma Therapy Assessment Questionnaire; CBC, complete blood count, total eosinophil count; Consent, obtain informed consent; ECP, plasma eosinophilic cationic protein; Chem, chemistry; IgE, serum IgE; Preg, pregnancy test in those reaching menarche; ENO, exhaled nitric oxide; DD, dispense diary; DEPFM, dispense electronic peak flow meter; RD, review symptom diary; FO/FEV1, forced oscillation and spirometry before and after bronchodilator treatment (∗ indicates no bronchodilator testing at this visit); ULT, urinary leukotriene measurement; max BD, maximal bronchodilator response; Gen, genetics analysis; Skin, allergen skin tests; TC, telephone call; EXIT, completion and discharge from study. Treatments: ICS, Inhaled corticosteroid. Inhaled fluticasone propionate (Flovent Diskus 100 μg per inhalation) or corresponding placebo administered as 1 inhalation twice daily. LTRA, Leukotriene receptor antagonist. Montelukast tablet (5 mg for those 6-14 years and 10 mg for those years) or corresponding placebo administered as 1 tablet once daily at night. Journal of Allergy and Clinical Immunology  , DOI: ( /j.jaci )

3 FIG 2 Scattergrams of exhaled nitric oxide (visit 1) by peripheral blood eosinophils, IgE, plasma eosinophilic cationic protein, and urinary leukotriene measurement E4 (on the log scale). Journal of Allergy and Clinical Immunology  , DOI: ( /j.jaci )

Download ppt "Relationship of exhaled nitric oxide to clinical and inflammatory markers of persistent asthma in children  Robert C. Strunk, MD, Stanley J. Szefler,"

Similar presentations

Individualized therapy for persistent asthma in young children

Individualized therapy for persistent asthma in young children
Volume 119, Issue 4, Pages (April 2001)

Volume 119, Issue 4, Pages (April 2001)
Adherence with montelukast or fluticasone in a long-term clinical trial: Results from the Mild Asthma Montelukast Versus Inhaled Corticosteroid Trial 

Adherence with montelukast or fluticasone in a long-term clinical trial: Results from the Mild Asthma Montelukast Versus Inhaled Corticosteroid Trial 
A proof-of-concept study of the effect of a novel H3-receptor antagonist in allergen- induced nasal congestion  William T. Barchuk, MD, Anne Marie Salapatek,

A proof-of-concept study of the effect of a novel H3-receptor antagonist in allergen- induced nasal congestion  William T. Barchuk, MD, Anne Marie Salapatek,
Simultaneously increased fraction of exhaled nitric oxide levels and blood eosinophil counts relate to increased asthma morbidity  Andrei Malinovschi,

Simultaneously increased fraction of exhaled nitric oxide levels and blood eosinophil counts relate to increased asthma morbidity  Andrei Malinovschi,
Asthma Yardstick Annals of Allergy, Asthma & Immunology

Asthma Yardstick Annals of Allergy, Asthma & Immunology
Jonathan Malka, MD, David T

Jonathan Malka, MD, David T
Asthma morbidity among inner-city adolescents receiving guidelines-based therapy: Role of predictors in the setting of high adherence  Rebecca S. Gruchalla,

Asthma morbidity among inner-city adolescents receiving guidelines-based therapy: Role of predictors in the setting of high adherence  Rebecca S. Gruchalla,
Guideline-defining asthma clinical trials of the National Heart, Lung, and Blood Institute's Asthma Clinical Research Network and Childhood Asthma Research.

Guideline-defining asthma clinical trials of the National Heart, Lung, and Blood Institute's Asthma Clinical Research Network and Childhood Asthma Research.
Alexandra Kazaks, MA, RD, Janet Y. Uriu-Adams, PhD, Judith S

Alexandra Kazaks, MA, RD, Janet Y. Uriu-Adams, PhD, Judith S
Theresa W. Guilbert, MD, David T. Mauger, PhD, David B

Theresa W. Guilbert, MD, David T. Mauger, PhD, David B
The Role of the Primary Care Physician in Helping Adolescent and Adult Patients Improve Asthma Control  Barbara P. Yawn, MD, MSc  Mayo Clinic Proceedings 

The Role of the Primary Care Physician in Helping Adolescent and Adult Patients Improve Asthma Control  Barbara P. Yawn, MD, MSc  Mayo Clinic Proceedings 
Stephen P. Peters, MD, PhD, Eugene R. Bleecker, MD, Susan J

Stephen P. Peters, MD, PhD, Eugene R. Bleecker, MD, Susan J
Comparative efficacy and anti-inflammatory profile of once-daily therapy with leukotriene antagonist or low-dose inhaled corticosteroid in patients with.

Comparative efficacy and anti-inflammatory profile of once-daily therapy with leukotriene antagonist or low-dose inhaled corticosteroid in patients with.
Individualized therapy for persistent asthma in young children

Individualized therapy for persistent asthma in young children
Long-term comparison of 3 controller regimens for mild-moderate persistent childhood asthma: The Pediatric Asthma Controller Trial  Christine A. Sorkness,

Long-term comparison of 3 controller regimens for mild-moderate persistent childhood asthma: The Pediatric Asthma Controller Trial  Christine A. Sorkness,
Fluticasone furoate nasal spray: A single treatment option for the symptoms of seasonal allergic rhinitis  Harold B. Kaiser, MD, Robert M. Naclerio, MD,

Fluticasone furoate nasal spray: A single treatment option for the symptoms of seasonal allergic rhinitis  Harold B. Kaiser, MD, Robert M. Naclerio, MD,
Randomized controlled trial of a ragweed allergy immunotherapy tablet in North American and European adults  Peter S. Creticos, MD, Jennifer Maloney,

Randomized controlled trial of a ragweed allergy immunotherapy tablet in North American and European adults  Peter S. Creticos, MD, Jennifer Maloney,
Allergic Rhinitis and Its Impact on Asthma

Allergic Rhinitis and Its Impact on Asthma
Alefacept (lymphocyte function-associated molecule 3/IgG fusion protein) treatment for atopic eczema  Dagmar Simon, MD, Jennifer Wittwer, MD, Ganna Kostylina,

Alefacept (lymphocyte function-associated molecule 3/IgG fusion protein) treatment for atopic eczema  Dagmar Simon, MD, Jennifer Wittwer, MD, Ganna Kostylina,

Similar presentations

Ads by Google